Spence Mcclelland

Board Member at Pure Life Renal

Spence McClelland joined NMP in 2010 and supports the firm’s investments in healthcare, software, and tech-enabled services. Spence is focused on reviewing investment opportunities and on working with portfolio company management teams to develop and execute their strategic plans. He also currently represents NMP on the boards of Array Health, Envera Health, Hospicelink, and serves as a board observer for Streamline Health and Wellcentive. Spence was previously a board member of Change Healthcare (acquired by Emdeon).

Prior to joining NMP, Spence was a co-founder of RGC Advisors, an entity formed to make acquisitions in the home health industry. Previously, he worked in the corporate development group of Healthways, Inc., where he was responsible for identifying, evaluating, and executing acquisitions and strategic partnerships for the company. In addition, he developed numerous business plans on potential new markets, channels, and business models for the company’s solutions. Prior to joining Healthways, Spence worked at Willis Stein & Partners a private equity firm and he has also worked in the investment banking groups of J.C. Bradford & Co. and DLJ / Credit Suisse First Boston.

Spence is a past chairman of Venture Atlanta and on the Board of Directors of the Southern Capital Forum.

Links